Energy scales, biotech borrows, the tail compounds
Thirteen deals printed last week and together they moved roughly $1.2 billion. The capital did not spread evenly, and that is the story. Three energy and infrastructure financings accounted for about $750 million. A single life-sciences term loan carried another $400 million of capacity. Everything else sat in a long tail of working-capital facilities, most of them under $3 million.
That barbell shape, heavy at both ends and light in the middle, is asset-based finance in miniature. Big institutional tickets chasing contracted, long-duration cash flows on one side. Granular, self-liquidating collateral funding the real economy on the other. Same market, two very different underwriting jobs. Here are the deals that mattered and what each one signals.
$400M Hercules Capital expands Dyne Therapeutics’ non-dilutive term loan
Hercules Capital expanded its non-dilutive senior secured term loan to Dyne Therapeutics to up to $400 million of total capacity. Dyne is a clinical-stage biotech advancing treatments for two genetically driven neuromuscular diseases, Duchenne muscular dystrophy and myotonic dystrophy type 1. Around $200 million has been drawn, with a similar amount still available across milestone-linked tranches.
Why it matters:
This is venture debt doing what equity used to do. Dyne funds two potential US launches without issuing shares into a volatile biotech tape, and Hercules holds a senior secured position with milestone gates that release capital only as the science de-risks. The structure, not the headline number, is the innovation.
Key risks:
The exposure is binary. A clinical or regulatory miss can impair a credit that looks healthy on every financial metric, and the collateral is largely intangible. Runway, cash burn and milestone timing all sit close to the centre of the underwriting.
Opportunity:
Premium yield and a senior secured claim on companies that, a few years ago, would have had to dilute shareholders to fund the same runway. For managers who can diligence the science, life-sciences debt offers returns that are hard to find elsewhere in senior credit.
$325M Spearmint Energy clubs a facility for grid-scale battery storage
A club of Nuveen Energy Infrastructure Credit, Elda River Capital Management, Harrison Street Asset Management and Aiga Capital Partners provided Spearmint Energy a $325 million debt facility. Spearmint builds and operates grid-scale battery storage in the ERCOT market in Texas, and the capital backs both operating assets and a development pipeline.
Why it matters:
Institutional credit is no longer dabbling in the energy transition. Nuveen turns up here and recently put preferred tax equity into community-solar developer Solar Landscape as well. Credit platforms are building concentrated, repeat exposure to storage and distributed solar through private structures rather than public markets.
Key risks:
Construction and completion risk, dependence on the investment tax credit regime, the split between merchant and contracted revenue, and battery degradation over the asset’s life. These are long-duration assets, so they carry real rate sensitivity too.
Opportunity:
Long-dated, often contracted and inflation-linked cash flows that match insurance and pension liabilities better than almost anything else on offer. Storage is becoming the connective tissue of a grid under strain from data-centre demand and intermittent renewables.
$300M Terawatt Infrastructure closes its first commercial bank facility
Terawatt Infrastructure closed its first commercial bank facility, up to $300 million over five years, structured by RBC Capital Markets with SMBC and UBS in the syndicate. Terawatt builds and operates charging depots for electric and autonomous fleets and counts Waymo among its customers.
Why it matters:
The facility is senior secured, with a committed tranche and an incremental option on top. A first bank facility for a category like this is a signal in itself. Fleet-charging infrastructure is being underwritten as an emerging asset class, with a bank syndicate rather than venture capital carrying the risk.
Key risks:
Buildout and permitting friction, counterparty and customer concentration, the utilisation ramp as fleets electrify, and the J-curve between capex today and revenue later.
Opportunity:
Early-mover exposure to infrastructure that sits underneath two structural shifts at once, fleet electrification and autonomy. Matched-duration capital against long-life assets, with a structure that scales as the network grows.
$125M M&T Bank leads an oversubscribed revolver for Solar Landscape
M&T Bank led an oversubscribed $125 million revolving credit facility for Solar Landscape, a distributed-energy developer that builds community and commercial solar on commercial rooftops. Flagstar, Atlantic Union and Valley Bank joined, and M&T syndicated the line as the developer’s pipeline outgrew its original working-capital facility.
Why it matters:
The money funds projects from origination through construction readiness, which is exactly the development-stage window where capital is hardest to source. It is also a reminder that banks still compete hard where distributed-solar credit fits their box, even as they retrench elsewhere.
Key risks:
Development-stage execution, interconnection and permitting delays, pipeline conversion, and sensitivity to policy and the tax-credit backdrop.
Opportunity:
A revolving structure that lets the developer keep multiple projects moving at once, and lets lenders take exposure to distributed generation with bank-grade structure and syndication.
$33M Wingspire Capital backs a secure communications platform
Wingspire Capital provided a $33 million first-out revolver and term loan to a secure communications and computing business, a defence-adjacent credit.
Why it matters:
The first-out structure carves up risk inside a single facility, allocating the safest dollars to the first-out lender and leaving room for a last-out tranche to price for more risk. It is a clean example of how structure, not just collateral, drives the risk profile in a single deal.
Key risks:
Customer and contract concentration typical of specialist technology and defence suppliers, and the usual borrowing-base and covenant exposures inside a leveraged ABL structure.
Opportunity:
Mid-market exposure with structural seniority and pricing that reflects where the lender sits in the waterfall.
The specialty tail: ABL at every scale
Underneath the headline tickets, the bread-and-butter of asset-based lending kept turning. Beacon Bank and Stream Finance backed Capstone Building Supplies with an $11.5 million revolver. SixCap Healthcare Finance lent $3 million against a skilled-nursing portfolio. Culain Capital Funding put $2.5 million of accounts-receivable financing behind a materials distributor. JPalmer Collective backed Rambler Sparkling Water with a $2.5 million asset-based working-capital line. Amerisource Business Capital funded a fishing-gear retailer with a $2.5 million working-capital and cash-flow facility. SouthStar Capital appeared twice, with $0.8 million of A/R financing for a home healthcare provider and $0.6 million of purchase-order and A/R financing for a government contractor and manufacturer. National Business Capital opened a $0.2 million flex line for a coffee retailer.
Why it matters:
This is where the asset class actually lives. Small individually, but in aggregate it is the quiet backbone of working capital across distribution, retail, beverage, building supplies and healthcare receivables. With banks still selective on smaller credits, specialist lenders are filling the gap and pricing it well.
Key risks:
Collateral dilution, receivables fraud, customer concentration and the seasonality baked into consumer and retail borrowers. A fishing-gear retailer, a coffee brand and a sparkling-water company all carry demand patterns that move the borrowing base around through the year.
Opportunity:
Diversification, self-liquidating collateral and genuine pricing power, precisely because bank retrenchment has left room for specialist lenders to underwrite credits the big balance sheets have stepped back from.
Takeaways
Four signals worth carrying into the week ahead.
- Bank syndicates are bifurcating: They are walking away from plenty and competing hard where they fit. The Solar Landscape and Terawatt deals show where banks still want to lead.
- Non-dilutive debt is reshaping life sciences: Milestone-gated term loans are letting clinical-stage companies fund launches without diluting equity, and lenders are getting paid for the binary risk.
- Institutional credit is going deep on the energy transition: The same names keep showing up across storage and distributed solar, building concentrated, repeat exposure through private structures.
- The specialty tail compounds: From a $33 million first-out revolver to an $800k healthcare receivables line, the small deals are where the volume quietly accumulates, and where data discipline decides who scales.
How Cardo AI helps Asset Managers and Lenders
From a $400 million milestone-gated term loan to an $800k receivables line, the operational requirement is identical. Collect, normalise, monitor and report on loan and collateral data, continuously, across wildly different asset types. That is the operating system Cardo AI was built to be.
- Loan tape ingestion across any source or format
- Borrowing base, eligibility and waterfall computation
- Concentration, covenant and trigger monitoring
- Portfolio analytics and stress testing
- Institutional-grade investor reporting
- Multi-asset-class onboarding, from battery-storage facilities to skilled-nursing portfolios
As the deals get more varied, the managers who can actually see their portfolios, in close to real time and across every collateral type, are the ones who keep scaling. If your monitoring has not kept pace with your origination, that is a conversation worth having.
Sources
ABL Advisor deal tables (June 22–25, 2026); company press releases via Business Wire, GlobeNewswire, PR Newswire and Bloomberg; ABF Journal; and issuer investor relations pages.
If you’re scaling into new asset classes or just tired of stitching data together in spreadsheets, book a demo.